Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Top Ten Searches
gynecomastia empyema henoch–schönlein otitis media dyspnea jaundice ventricle lyme immunodeficiency coolingYour Article Summary
Clinical potency of methotrexate, aminopterin, talotrexin and pemetrexed in childhood leukemias
Cancer Chemotherapy and Pharmacology, 10/05/09
Norris R et al. – Aminopterin does not appear to offer any advantage over methotrexate for the treatment of childhood ALL.
Methods- Compared in vitro cytotoxicity of methotrexate, aminopterin, pemetrexed, and talotrexin
- Panel of 6 pediatric leukemia and lymphoma cell lines using sulforhodamine B assay
- Also contrasted activity of drugs in context of clinically achievable (tolerable) drug exposures using area under plasma concentration–time curve (AUC)
- Defined each agent’s clinical potency index (CPI) as AUC achieved with standard pediatric dosing regimens divided by in vitro IC50
- Across all cell lines, talotrexin (median IC50 7 nM) and aminopterin (median IC50 17 nM) had lower IC50’s than methotrexate (median IC50 78 nM) and pemetrexed (median IC50 155 nM)
- CPI for methotrexate (median 0.9) significantly greater than that for aminopterin (median 0.4)
- CPI for methotrexate (median 0.9)significantly greater than that for aminopterin (median 0.4)
- Pemetrexed had significantly better CPI (median 13) than traditional antifols
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy of Fluconazole Prophylaxis for Prevention of Invasive Fungal Infection in Extremely Low Birth Weight Infants
The Pediatric Infectious Disease Journal, 11/25/09
Antibody drop in newborns congenitally infected by Trypanosoma cruzi treated with benznidazole
Tropical Medicine & International Health, 11/25/09
A Randomized Trial of Nebulized 3% Hypertonic Saline With Epinephrine in the Treatment of Acute Bronchiolitis in the Emergency Department
Archives of Pediatrics and Adolescent Medicine, 11/23/09
Today in Pediatric Heme/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
High-risk neuroblastoma: a therapy in evolution
Pediatric Hematology and Oncology, 11/25/09
Staphylococcus Aureus Bacteremia in Pediatric Patients With Cancer
The Pediatric Infectious Disease Journal, 11/25/09
Facial rhabdomyosarcoma with an isolated pancreatic metastasis
Pediatric Surgery International, 11/25/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


